Top compounds associated with response to PILRB


Feature Type Standardized
Nominal ANOVA
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.06 0.09
mRNA skepinone-L CTRPv2 pan-cancer AAC 0.089 0.09
mRNA NSC95397 CTRPv2 pan-cancer AAC 0.057 0.09
mRNA BRD-K13185470 CTRPv2 pan-cancer AAC 0.12 0.09
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.061 0.1
mRNA A-804598 CTRPv2 pan-cancer AAC 0.079 0.1
mRNA AZD4547 CTRPv2 pan-cancer AAC -0.064 0.1
mRNA HBX-41108 CTRPv2 pan-cancer AAC 0.071 0.1
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.058 0.1
mRNA Compound 23 citrate CTRPv2 pan-cancer AAC 0.056 0.1
Download CSV